Literature DB >> 21827793

Activity of cholinergic neurons in the laterodorsal tegmental nucleus during emission of 22kHz vocalization in rats.

Stefan M Brudzynski1, Amaka Iku, Alison Harness Neé Savoy.   

Abstract

It has been postulated that the ascending cholinergic tegmental system is responsible for the initiation of the aversive emotional state with a concomitant alarm vocalization in the rat. It is assumed that the activity of cholinergic neurons of the laterodorsal tegmental nucleus (LDT) will cause release of acetylcholine in the target areas and will initiate the emission of 22kHz vocalizations. The goal of the present study was to test the hypothesis that the cholinergic neurons of the LDT increase their activity during emission of 22kHz alarm calls. Vocalizations were induced by an air puff or by intrahypothalamic-preoptic injection of carbachol. The activity of the LDT cholinergic neurons was studied by a double histochemical labelling for choline acetyltransferase, as a marker of cholinergic somata, and for c-Fos protein, as a marker of cells with heighten metabolic activity. Both air puff stimulation and intracerebral carbachol induced comparable 22kHz alarm vocalizations. The activity of neurons in the LDT was significantly higher during prolonged emission of 22kHz alarm calls induced by air puff or injection of carbachol than in the non-vocalizing or low-vocalizing controls. There were approximately two times more of all c-Fos-labelled cells in the LDT of vocalizing animals and 2.5 times more active cholinergic neurons during prolonged 22kHz vocalization than in the control conditions without vocalization. However, the active cholinergic neurons constituted only a small proportion of all active LDT cells (2.3%). At the same time, there were no significant increases in the number of c-Fos-labelled cells in the neighbouring pedunculopontine nucleus (PPT). These findings lead to the conclusion that the neurons of the LDT, including cholinergic neurons, but not those of the PPT, significantly increased their activity during prolonged emission of alarm vocalizations, as evidenced by the c-Fos immunoreactivity.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21827793     DOI: 10.1016/j.bbr.2011.07.040

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  6 in total

Review 1.  The ascending mesolimbic cholinergic system--a specific division of the reticular activating system involved in the initiation of negative emotional states.

Authors:  Stefan M Brudzynski
Journal:  J Mol Neurosci       Date:  2013-11-24       Impact factor: 3.444

Review 2.  Rats selectively bred for low levels of play-induced 50 kHz vocalizations as a model for autism spectrum disorders: a role for NMDA receptors.

Authors:  Jeffrey Burgdorf; Joseph R Moskal; Stefan M Brudzynski; Jaak Panksepp
Journal:  Behav Brain Res       Date:  2013-04-23       Impact factor: 3.332

3.  Negative Affect-Associated USV Acoustic Characteristics Predict Future Excessive Alcohol Drinking and Alcohol Avoidance in Male P and NP Rats.

Authors:  James M Reno; Neha Thakore; Lawrence K Cormack; Timothy Schallert; Richard L Bell; W Todd Maddox; Christine L Duvauchelle
Journal:  Alcohol Clin Exp Res       Date:  2017-02-23       Impact factor: 3.455

4.  Post-weaning stroking stimuli induce affiliative behavior toward humans and influence brain activity in female rats.

Authors:  Shota Okabe; Yuki Takayanagi; Masahide Yoshida; Tatsushi Onaka
Journal:  Sci Rep       Date:  2021-02-15       Impact factor: 4.379

Review 5.  Pharmacology of Ultrasonic Vocalizations in adult Rats: Significance, Call Classification and Neural Substrate.

Authors:  Stefan M Brudzynski
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

6.  Effect of Neuropeptide S Administration on Ultrasonic Vocalizations and Behaviour in Rats with Low vs. High Exploratory Activity.

Authors:  Kadri Kõiv; Denis Matrov; Trine Uusen; Jaanus Harro
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.